Equine metabolic syndrome may adversely affect harvested stem cells

Viability is a concern with stem cells extracted from fat tissue of horses with this metabolic condition.

Equine metabolic syndrome (EMS) may reduce the viability of stem cells harvested from the fat tissue of affected horses, according to research from Poland and Germany.

Stem cells harvested from the fat tissue of horses with EMS were less likely to survive and proliferate than were those extracted from healthy horses.

Stem cells isolated from fat (adipose) tissue are increasingly used in regenerative medicine. Because they have the ability to differentiate into multiple types of cells and proliferate, stem cells are injected directly into soft-tissue lesions or joints to boost healing.

However, recent research into human regenerative medicine has suggested the stem cells harvested from fat tissue in obese patients or those with insulin resistance are less viable than those from healthy patients.

Click here to learn why obesity isn’t necessarily a sign of laziness in horses. 

To see if the same effect occurs in horses, researchers at the Wroclaw University of Environmental and Life Sciences isolated stem cells from fat tissue near the tail heads of six healthy horses and six that had EMS. After the cells were cultured, the researchers examined them for a variety of characteristics, including morphology, number and gene expressions, and compared the results.

The data showed that stem cells harvested from the fat tissue of horses with EMS were less likely to survive and proliferate than were those extracted from healthy horses. What’s more, the stem cells from EMS horses had structural flaws and impaired mitochondria, which regulate cell metabolism.

In addition, the researchers detected accumulations of toxic compounds associated with oxidative stress within the stems cells, which could likely lead to premature death. They conclude that “treating [stem cells from EMS horses] with antioxidants before their clinical application to improve mitochondrial function appears to be justified.”

Reference: “Equine metabolic syndrome affects viability, senescence, and stress factors of equine adipose-derived mesenchymal stromal stem cells: New insight into EqASCs isolated from EMS horses in the context of their aging,” Oxidative Medicine and Cellular Longevity, November 2015 (click here for abstract) 

This article first appeared in EQUUS issue #461

Don’t miss out! With the free weekly EQUUS newsletter, you’ll get the latest horse health information delivered right to your in basket! If you’re not already receiving the EQUUS newsletter, click here to sign up. It’s *free*!




Related Posts

Gray horse head in profile on EQ Extra 89 cover
What we’ve learned about PPID
Do right by your retired horse
Tame your horse’s anxiety
COVER EQ_EXTRA-VOL86 Winter Care_fnl_Page_1
Get ready for winter!


"*" indicates required fields


Additional Offers

Additional Offers
This field is for validation purposes and should be left unchanged.